Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy
Radiofrequency ablation is used to treat metastatic colorectal cancer. In this study, the authors show that incomplete ablation of tumours results in metastases and show in mouse models that the chemokine CCL2 recruits myeloid cells to the partially ablated tumours, which can block T cell function.
Guardado en:
Autores principales: | Liangrong Shi, Junjun Wang, Nianhua Ding, Yi Zhang, Yibei Zhu, Shunli Dong, Xiaohui Wang, Changli Peng, Chunhui Zhou, Ledu Zhou, Xiaodong Li, Hongbing Shi, Wei Wu, Xueyin Long, Changping Wu, Weihua Liao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7ee06799e14541969149a6f48d4cd21b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Transcatheter chemoembolization plus percutaneous radiofrequency ablation versus laparoscopic radiofrequency ablation: improved outcome for inoperable hepatocellular carcinoma
por: Bin Chai, et al.
Publicado: (2021) -
Radiofrequency ablation of the lateral palatal space for snoring
por: B. Tucker Woodson, et al.
Publicado: (2017) -
Optical signatures of radiofrequency ablation in biological tissues
por: Pranav Lanka, et al.
Publicado: (2021) -
Combination therapy with low-frequency ultrasound irradiation and radiofrequency ablation as a synergistic treatment for pancreatic cancer
por: Huiyang Wang, et al.
Publicado: (2021) -
Predictors of Recurrence of AF in Patients After Radiofrequency Ablation
por: Iskren Garvanski, et al.
Publicado: (2019)